NORMA eResearch @NCI Library

Paid and unpaid lost productivity due to premature mortality from cancer in Europe in 2018

Ortega Ortega, Marta, Hanly, Paul, Pearce, Alison, Soerjomatarm, Isabelle and Sharp, Linda (2020) Paid and unpaid lost productivity due to premature mortality from cancer in Europe in 2018. In: European Health Economics Association, EuHEA 2020 Conference, 7-10 July 2020, Oslo. (Submitted)

Full text not available from this repository.
Official URL: https://www.euhea.eu/abstracts_conference_2020.htm...

Abstract

Objectives: When someone dies prematurely from cancer this represents a loss of productivity for society. This loss can be valued and provides an alternative measure of the cancer burden. We estimated costs of paid and unpaid productivity lost due to cancer-related premature mortality in Europe in 2018.

Methods: Costs were estimated for all cancers and 23 sites; and for all Europe and 30 countries. Deaths aged 15-64 by cancer site, age, gender and country were abstracted from GLOBOCAN. Unpaid time lost was derived from Eurostat. Paid and unpaid (housework, caring) productivity losses were valued using the Human Capital Approach, making adjustments for labour force participation and unemployment. Costs are in €2018.

Results: 347,149 premature cancer deaths occurred (60% male/40% female). Total cost of productivity lost due to cancer in Europe in 2018 was €104.6 billion (51% due to paid work; 21% to unpaid work among workers; 28% to unpaid work among non-workers). Loss was highest in Western Europe (€52.6 billion). The most costly cancer was lung (€21.7 billion), followed by breast (€10.6 billion). Females accounted for 34% of the paid work cost but near half of the unpaid work cost (49%). Among workers, the average cost/death was €215,535; Hodgkin lymphoma was most costly (€403,980) and prostate cancer least costly (€122,984). The average cost/death for non-workers was €85,692, with breast cancer most costly (€63,234) and prostate least costly (€104,670).

Discussion: Lost productivity costs due to cancer-related premature mortality are significant. These findings can help inform cancer control policy decisions.

Item Type: Conference or Workshop Item (Paper)
Additional Information: Paper published in International Journal of Cancer, 150 (4). pp. 580-593. ISSN 1097-0215. Separate NORMA record: http://norma.ncirl.ie/5055/
Subjects: D History General and Old World > D History (General) > D901 Europe (General)
Q Science > Life sciences > Medical sciences > Pathology > Tumors > Cancer
H Social Sciences > Economics > Microeconomics > Production (Economic theory) > Industrial productivity > Labor productivity
Divisions: School of Business > Staff Research and Publications
Related URLs:
Depositing User: Clara Chan
Date Deposited: 23 Mar 2022 12:03
Last Modified: 23 Mar 2022 12:42
URI: http://norma.ncirl.ie/id/eprint/5562

Actions (login required)

View Item View Item